Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023785879> ?p ?o ?g. }
- W2023785879 endingPage "5260" @default.
- W2023785879 startingPage "5247" @default.
- W2023785879 abstract "Ligand efficiency (LE) and lipophilic efficiency (LipE) are two important indicators of “drug-likeness”, which are dependent on the molecule’s activity and physicochemical properties. We recently reported a furano-pyrimidine Aurora kinase inhibitor 4 (LE = 0.25; LipE = 1.75), with potent activity in vitro; however, 4 was inactive in vivo. On the basis of insights obtained from the X-ray co-crystal structure of the lead 4, various solubilizing functional groups were introduced to optimize both the activity and physicochemical properties. Emphasis was placed on identifying potential leads with improved activity as well as better LE and LipE by exercising tight control over the molecular weight and lipophilicity of the molecules. Rational optimization has led to the identification of Aurora kinase inhibitor 27 (IBPR001; LE = 0.26; LipE = 4.78), with improved in vitro potency and physicochemical properties, resulting in an in vivo active (HCT-116 colon cancer xenograft mouse model) anticancer agent." @default.
- W2023785879 created "2016-06-24" @default.
- W2023785879 creator A5002576867 @default.
- W2023785879 creator A5006230785 @default.
- W2023785879 creator A5017391108 @default.
- W2023785879 creator A5023745818 @default.
- W2023785879 creator A5024236839 @default.
- W2023785879 creator A5033131438 @default.
- W2023785879 creator A5036124937 @default.
- W2023785879 creator A5036592907 @default.
- W2023785879 creator A5044218966 @default.
- W2023785879 creator A5049256333 @default.
- W2023785879 creator A5050488521 @default.
- W2023785879 creator A5050512204 @default.
- W2023785879 creator A5053802719 @default.
- W2023785879 creator A5058918636 @default.
- W2023785879 creator A5061434695 @default.
- W2023785879 creator A5062705128 @default.
- W2023785879 creator A5063679299 @default.
- W2023785879 creator A5071634459 @default.
- W2023785879 creator A5090460332 @default.
- W2023785879 date "2013-06-28" @default.
- W2023785879 modified "2023-10-02" @default.
- W2023785879 title "Optimization of Ligand and Lipophilic Efficiency To Identify an in Vivo Active Furano-Pyrimidine Aurora Kinase Inhibitor" @default.
- W2023785879 cites W1966521331 @default.
- W2023785879 cites W1969073798 @default.
- W2023785879 cites W1978959144 @default.
- W2023785879 cites W1981073960 @default.
- W2023785879 cites W1991590537 @default.
- W2023785879 cites W1994753024 @default.
- W2023785879 cites W2002809300 @default.
- W2023785879 cites W2010546629 @default.
- W2023785879 cites W2012406630 @default.
- W2023785879 cites W2015989848 @default.
- W2023785879 cites W2016462887 @default.
- W2023785879 cites W2029335488 @default.
- W2023785879 cites W2032660344 @default.
- W2023785879 cites W2033989981 @default.
- W2023785879 cites W2049885874 @default.
- W2023785879 cites W2064261028 @default.
- W2023785879 cites W2069910776 @default.
- W2023785879 cites W2086070714 @default.
- W2023785879 cites W2098517908 @default.
- W2023785879 cites W2106942695 @default.
- W2023785879 cites W2111254482 @default.
- W2023785879 cites W2113696655 @default.
- W2023785879 cites W2128553601 @default.
- W2023785879 cites W2132629607 @default.
- W2023785879 cites W2138072853 @default.
- W2023785879 cites W2138984732 @default.
- W2023785879 cites W2144307464 @default.
- W2023785879 cites W2147194005 @default.
- W2023785879 cites W2147505534 @default.
- W2023785879 cites W2151779190 @default.
- W2023785879 cites W2160475600 @default.
- W2023785879 cites W2162166182 @default.
- W2023785879 doi "https://doi.org/10.1021/jm4006059" @default.
- W2023785879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23808327" @default.
- W2023785879 hasPublicationYear "2013" @default.
- W2023785879 type Work @default.
- W2023785879 sameAs 2023785879 @default.
- W2023785879 citedByCount "37" @default.
- W2023785879 countsByYear W20237858792013 @default.
- W2023785879 countsByYear W20237858792014 @default.
- W2023785879 countsByYear W20237858792015 @default.
- W2023785879 countsByYear W20237858792016 @default.
- W2023785879 countsByYear W20237858792017 @default.
- W2023785879 countsByYear W20237858792018 @default.
- W2023785879 countsByYear W20237858792019 @default.
- W2023785879 countsByYear W20237858792020 @default.
- W2023785879 countsByYear W20237858792021 @default.
- W2023785879 countsByYear W20237858792022 @default.
- W2023785879 countsByYear W20237858792023 @default.
- W2023785879 crossrefType "journal-article" @default.
- W2023785879 hasAuthorship W2023785879A5002576867 @default.
- W2023785879 hasAuthorship W2023785879A5006230785 @default.
- W2023785879 hasAuthorship W2023785879A5017391108 @default.
- W2023785879 hasAuthorship W2023785879A5023745818 @default.
- W2023785879 hasAuthorship W2023785879A5024236839 @default.
- W2023785879 hasAuthorship W2023785879A5033131438 @default.
- W2023785879 hasAuthorship W2023785879A5036124937 @default.
- W2023785879 hasAuthorship W2023785879A5036592907 @default.
- W2023785879 hasAuthorship W2023785879A5044218966 @default.
- W2023785879 hasAuthorship W2023785879A5049256333 @default.
- W2023785879 hasAuthorship W2023785879A5050488521 @default.
- W2023785879 hasAuthorship W2023785879A5050512204 @default.
- W2023785879 hasAuthorship W2023785879A5053802719 @default.
- W2023785879 hasAuthorship W2023785879A5058918636 @default.
- W2023785879 hasAuthorship W2023785879A5061434695 @default.
- W2023785879 hasAuthorship W2023785879A5062705128 @default.
- W2023785879 hasAuthorship W2023785879A5063679299 @default.
- W2023785879 hasAuthorship W2023785879A5071634459 @default.
- W2023785879 hasAuthorship W2023785879A5090460332 @default.
- W2023785879 hasConcept C104317684 @default.
- W2023785879 hasConcept C116569031 @default.
- W2023785879 hasConcept C143065580 @default.
- W2023785879 hasConcept C150903083 @default.
- W2023785879 hasConcept C170493617 @default.